所罗门技术胎儿镜激光治疗双胎输血综合征的受血儿与供血儿基于分期的结局
单中心队列研究纳入402例接受所罗门技术激光治疗的TTTS双胎妊娠,按Quintero分期评估新生儿存活。出院时双胎存活303例(75.4%),各期双胎存活率无显著差异(P=0.062);III期供血儿存活率低于受血儿(69.8% vs 85.8%,P<0.0001)。双胎间体型不一致度>30%及脐动脉舒张末期血流缺失或反向与供血儿死亡相关,累积供血儿存活率从92%分别降至65%和48%。
要点
- III期TTTS供血儿存活率显著低于受血儿(69.8% vs 85.8%,P<0.0001)。
- 双胎间体型不一致度>30%时累积供血儿存活率由92%降至65%。
- 脐动脉舒张末期血流缺失或反向时累积供血儿存活率降至48%。
核心结论
- 所罗门技术可实现高比例的TTTS缓解及双胎存活;除非存在显著双胎间体型不一致和胎盘功能障碍,受血儿与供血儿存活率相当;III期TTTS中这种胎盘分配不均导致供血儿死亡增加,是妨碍双胎存活的主要因素。
研究设计与样本
- 约翰斯·霍普金斯胎儿治疗中心单中心研究,连续纳入402例接受所罗门技术激光治疗的TTTS双胎妊娠队列。
关键影像表现/征象
- 脐动脉舒张末期血流缺失或反向与供血儿死亡相关(Nagelkerke R2=0.38,P<0.001)。
- 双胎间体型不一致度增大与供血儿死亡相关(Nagelkerke R2=0.38,P<0.001)。
诊断标准与关键数值
- Quintero分期分布:I期80例(19.9%)、II期126例(31.3%)、III期169例(42.0%)、IV期27例(6.7%)。
- 出院时双胎存活:I期67/80(83.8%)、II期101/126(80.2%)、III期113/169(66.9%)、IV期22/27(81.5%),P=0.062。
- III期供血儿存活118/169(69.8%)vs 受血儿145/169(85.8%),χ2=26.076,P<0.0001。
- 累积供血儿存活率:双胎间体型不一致度>30%时由92%降至65%,脐动脉舒张末期血流缺失或反向时降至48%(P<0.001)。
临床应用与阅片要点
- 术后自发供血儿死亡53例(39.6%),占全部丢失的大多数。
- 激光术后双胎贫血-红细胞增多序列征发生19例(4.7%),复发性TTTS 11例(2.7%)需重复激光手术。
- 胎膜早破150例(37.3%),分娩中位孕周32+1周。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate twin survival stratified by Quintero stage in patients with twin-to-twin transfusion syndrome (TTTS) after Solomon laser treatment.
METHODS: This was a single-center study at Johns Hopkins Center for Fetal Therapy, investigating a cohort of consecutive twin pregnancies treated with the Solomon laser technique for TTTS. Preoperative Quintero stage, perioperative characteristics and obstetric factors were investigated in relation to neonatal survival of the recipient and donor twins at discharge. Determinants of twin survival were evaluated using univariate logistic regression and cumulative survival probability analyses.
RESULTS: Of 402 pregnancies with TTTS that underwent Solomon laser treatment, 80 (19.9%) were diagnosed with Quintero Stage-I TTTS, 126 (31.3%) with Stage II, 169 (42.0%) with Stage III and 27 (6.7%) with Stage IV. Post-laser twin anemia polycythemia sequence or recurrent TTTS occurred in 19 (4.7%) patients and 11 (2.7%) required repeat laser surgery. Preterm prelabor rupture of membranes occurred in 150 (37.3%) patients and median gestational age at delivery was 32 + 1 weeks. In 303 (75.4%) patients, both twins were alive at discharge; 67/80 (83.8%) were Stage I, 101/126 (80.2%) were Stage II, 113/169 (66.9%) were Stage III and 22/27 (81.5%) were Stage IV (P = 0.062). Donor twin survival was lower than that of recipients in cases with Stage-III TTTS (118/169 (69.8%) vs 145/169 (85.8%) (χ2 = 26.076, P < 0.0001)). Higher intertwin size discordance and absent or reversed umbilical artery (UA) end-diastolic velocity (EDV) were associated with donor demise (Nagelkerke R2, 0.38; P < 0.001). Overall, spontaneous post-laser donor demise occurred in 53 (39.6%) patients, accounting for the majority of all losses. Cumulative donor survival decreased from 92% to 65% when intertwin size discordance was >30% and to 48% when UA-EDV was absent or reversed (P < 0.001).
CONCLUSIONS: The Solomon laser technique achieves TTTS resolution and double twin survival in a high proportion of cases. Recipient and donor survival is comparable unless there is significant intertwin size discordance and placental dysfunction. This degree of unequal placental sharing, typically found in Stage-III TTTS, is the primary factor preventing double survival due to a higher rate of donor demise. © 2024 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Kyvernitakis I, Rosner M, Birk A, et al. Stage-based recipient and donor outcome in twin-to-twin transfusion syndrome treated by fetoscopic laser surgery using Solomon technique. Ultrasound Obstet Gynecol. 2024. PMID: 38379440. doi:10.1002/uog.27620
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。